wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52655045-0912D288-A684-449F-9774-381568C3CAE3
Q52655045-0912D288-A684-449F-9774-381568C3CAE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52655045-0912D288-A684-449F-9774-381568C3CAE3
Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade.
P2860
Q52655045-0912D288-A684-449F-9774-381568C3CAE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52655045-0912D288-A684-449F-9774-381568C3CAE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
85497b641ab4fb17ae7987e7e49f15105ba37324
P2860
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.